Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Director departure
Appointed director
|
|
Kintara Therapeutics, Inc. (DMPI)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 09/27/2022 |
10-K
| Annual Report for the period ended June 30, 2022 |
| 09/28/2021 |
10-K
| Annual Report for the period ended June 30, 2021 |
| 09/18/2020 |
10-K
| Annual Report for the period ended June 30, 2020 |
| 09/09/2019 |
10-K
| Annual Report for the period ended June 30, 2019 |
| 09/24/2018 |
10-K
| Annual Report for the period ended June 30, 2018 |
| 09/27/2017 |
10-K
| Annual Report for the period ended June 30, 2017 |
| 09/12/2016 |
10-K
| Annual Report for the period ended June 30, 2016 |
| 11/16/2015 |
10-K/A
| Annual Report for the period ended June 30, 2015 [amend] |
| 09/03/2015 |
10-K
| Annual Report for the period ended June 30, 2015 |
| 08/28/2014 |
10-KT
| Form 10-KT - Transition reports [Rule 13a-10 or 15d-10] |
| 03/10/2014 |
10-K
| Annual Report for the period ended December 31, 2013 |
| 12/20/2012 |
10-K/A
| Annual Report for the period ended June 30, 2012 [amend] |
| 10/15/2012 |
10-K
| Annual Report for the period ended June 30, 2012 |
| 09/28/2011 |
10-K
| Annual Report for the period ended June 30, 2011 |
|
|